Form 4 for INGN Inogen Inc
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-015041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-02 | 2023-03-01 | INGN | Glezer Stanislav | EVP, CTO | F - Tax | $15.56 | -3,710 | 6,841 | -35% | -$57.7K |
| D | 2023-03-02 | 2023-03-01 | INGN | Glezer Stanislav | EVP, CTO | A - Grant | $0.00 | +2,272 | 5,995 | +61% | $0 |
| D | 2023-03-02 | 2023-03-01 | INGN | Glezer Stanislav | EVP, CTO | M - OptEx | $0.00 | +4,556 | 9,409 | +94% | $0 |
| D | 2023-03-02 | 2023-02-28 | INGN | Glezer Stanislav | EVP, CTO | A - Grant | $0.00 | +28.1K | 28.1K | New | $0 |
| DM | 2023-03-02 | 2023-03-01 | INGN | Glezer Stanislav | EVP, CTO | M - OptEx | $0.00 | -4,556 | 7,686 | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 1,142 | $15.56 | 4,853 | D | — | — | (F2) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted award granted on March 1, 2022 and vested on March 1, 2023. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 2,568 | $15.56 | 6,841 | D | — | — | (F3) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023. |
| 3 | Common | Common Stock | 2023-03-01 | A | A | 2,272 | $0.00 | 5,995 | D | — | — | (F1) The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022. |
| 4 | Common | Common Stock | 2023-03-01 | M | A | 4,556 | $0.00 | 9,409 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2023-02-28 | A | A | 28,079 | $0.00 | 28,079 | D | — · — to — | 28,079 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F7) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. |
| 6 | Derivative | Restricted Stock Unit | 2023-03-01 | M | D | 3,787 | $0.00 | 7,573 | D | — · — to — | 3,787 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F6) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. |
| 7 | Derivative | Restricted Stock Unit | 2023-03-01 | M | D | 769 | $0.00 | 7,686 | D | — · — to — | 769 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F5) Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. |